Klotho Neurosciences, Inc. (NASDAQ: KLTO ), a specialty biotechnology company focused on developing cell and gene therapies for amyotrophic lateral sclerosis (ALS), Alzheimer's and Parkinson's disease ...
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson's disease on Monday and said it's on track to seek approval for the drug from the Food and Drug ...
AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...
Hello from San Diego, where I always happen to be, but where this weekend I had the delight of hanging out with coworkers ...
The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.
Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.
Stephen Knight, whose nonprofit saves lives by providing foster care for dogs while their owners focus on addiction recovery, ...
A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...
Michael J Fox has given an honest update on how he copes with Parkinson's disease. The star is best known for playing Marty ...
The funding comes from a county program that offers cash to businesses that want to expand locally and add at least 10 new ...
Although there is no cure, there are ways to relieve the tremors, stiffness, depression, anxiety, and memory problems caused ...
Construction workers and others look on as crews install the final beam for the $838 million, 500,000 square foot, ...